Organovo Holdings, Inc. Reminds Stockholders About Adjourned Special Meeting of Stockholders
Organovo Holdings, Inc. (“Organovo”) (Nasdaq: ONVO) convened, on
March 26, 2020, the special meeting of stockholders (the “Special
Meeting”) and then adjourned the Special Meeting until Tuesday,
April 7, 2020 10:00 A.M. Pacific Time at www.virtualshareholdermeeting.com/ONVO2020
to solicit additional proxies for Organovo Proposals Nos. 1 and 4.
Organovo Proposal No. 1 is to approve the issuance of shares of
Organovo common stock to the Tarveda Therapeutics, Inc. (“Tarveda”)
securityholders in the proposed merger and Organovo Proposal No. 4
is to approve the adoption of the Combined Organization 2020 Equity
Incentive Plan. These proposals are described in more detail in the
proxy statement/prospectus/information statement of Organovo dated
February 24, 2020, furnished to Organovo’s stockholders in
connection with the solicitation of proxies by the Organovo Board
of Directors for use at the Special Meeting. On March 16, 2020,
Organovo mailed a notice of change of location to stockholders of
record, in compliance with Delaware law, regarding Organovo moving
the Special Meeting to a virtual meeting format.
As previously announced, Organovo Proposals Nos. 2, 3 and 5 were
approved by the required votes present in person or proxy at the
Special Meeting prior to adjournment to solicit additional proxies
for Organovo Proposals Nos. 1 and 4.
The following section provides answers to frequently asked
questions stockholders may have regarding the adjourned Special
When will the adjourned Special Meeting of Stockholders be
The adjourned Special Meeting will be reconvened on Tuesday,
April 7, 2020 10:00 A.M. Pacific Time at www.virtualshareholdermeeting.com/ONVO2020.
How do I attend and vote at the adjourned Special Meeting
when it is reconvened?
As described in the proxy statement/prospectus/information
statement for the Special Meeting previously distributed, you are
entitled to participate in and vote at the Special Meeting if you
were a stockholder as of the close of business on February 14,
2020, the record date, or hold a legal proxy for the meeting
provided by your bank, broker, or nominee. To be admitted to the
adjourned Special Meeting when it is reconvened at www.virtualshareholdermeeting.com/ONVO2020,
you must enter the control number found on your proxy card or
voting instruction form you previously received.
You may vote during the Special Meeting by following the
instructions available on the meeting website during the
If I can’t attend the adjourned Special Meeting, or if I want
to submit my vote beforehand, can I do that?
Yes, you may use one of the following simple methods to provide
your voting instructions with respect to Organovo Proposals Nos. 1
- Vote by Internet: Go to the
website www.proxyvote.com. Have your 16-digit control number listed
on the proxy card or voting instruction form ready and follow the
online instructions. The 16-digit control number is located in the
rectangular box on the right side of your voting instruction
- Vote by Telephone: Please call the
toll free number listed on your proxy card or voting instruction
form and follow the instructions provided.
- Vote by Mail: Mark, sign, date and
return your proxy card or voting instruction form and return it in
the postage-paid return envelope provided.
Your vote must be received by 11:59 PM Eastern Time on April 6,
2020 to be counted. After this time, the only way to cast a vote is
at the adjourned Special Meeting on April 7, 2020.
Who do I contact if I need assistance voting my
If you need assistance voting your shares, please call D.F. King
& Co., Inc. toll free at (800) 431-9646 or toll at (212)
Important Information and Where to Find It
This communication may be deemed to be solicitation material in
respect to the proposed transaction between Organovo and Tarveda.
On February 24, 2020, Organovo initially filed the proxy
statement/prospectus/information statement (the “Definitive Proxy
Statement”) with the SEC. Organovo mailed the Definitive Proxy
Statement to its stockholders on or about February 26, 2020. Each
party may file other documents with the Securities and Exchange
Commission (“SEC”) in connection with the proposed merger. BEFORE
MAKING ANY VOTING OR INVESTMENT DECISION, INVESTORS AND
STOCKHOLDERS ARE URGED TO READ THESE MATERIALS CAREFULLY AND IN
THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT
ORGANOVO, TARVEDA THE PROPOSED MERGER AND RELATED MATTERS.
Investors and stockholders may obtain, free of charge, copies of
the Definitive Proxy Statement and any other documents filed by
Organovo with the SEC in connection with the proposed transactions
at the SEC’s website (http://www.sec.gov) and on the investor
relations section of Organovo’s website at ir.organovo.com.
Investors and stockholders are urged to read the Definitive Proxy
Statement and the other relevant materials before making any voting
or investment decision with respect to the proposed merger and the
This communication does not constitute an offer to sell or
solicitation of an offer to buy any securities, nor will there be
any sale of securities in any jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such
Participants in the Solicitation
Organovo and its directors and executive officers and Tarveda
and its directors and executive officers may be deemed to be
participants in the solicitation of proxies from the stockholders
of Organovo in connection with the proposed Merger. Information
regarding the special interests of the Organovo and Tarveda
directors and executive officers in the proposed Merger is included
in the Definitive Proxy Statement. Additional information regarding
the directors and executive officers of Organovo is included in
Organovo’s definitive proxy statement on Schedule 14A relating to
the 2019 Annual Meeting of Stockholders, filed with the SEC on July
26, 2019. These documents are available free of charge from the
sources indicated above.
version on businesswire.com: https://www.businesswire.com/news/home/20200331005881/en/
For Organovo Holdings, Inc. Taylor J. Crouch 858-224-1000
For Tarveda Therapeutics, Inc. Amanda Houlihan MacDougall +1 781
235 3060 firstname.lastname@example.org
Historical Stock Chart
From Jul 2020 to Aug 2020
Historical Stock Chart
From Aug 2019 to Aug 2020